Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey

Bone Marrow Transplantation - Tập 51 Số 6 - Trang 778-785 - 2016
D Niederwieser1,2, Helen Baldomero2, Jeff Szer3, Michael Gratwohl4, Mahmoud Aljurf5, Yoshiko Atsuta6, Luis Fernando Bouzas7, Dennis L. Confer8, Hildegard Greinix9, Mary M. Horowitz10, Minako Iida11, Jeff H. Lipton12, Mohamad Mohty13, Nicolás Novitzky14, José Enrique Casal Núñez15, Jakob Passweg2, Marcelo C. Pasquini10, Yoshihisa Kodera16, Jane Apperley17, Adriana Seber18, A Gratwohl2
1Department of Hematology-Oncology, University Hospital, Leipzig, Germany
2The Worldwide Network of Blood and Marrow Transplantation (WBMT) Transplant Activity Survey Office, University Hospital Basel, Basel, Switzerland
3The Australasian Bone Marrow Transplant Recipient Registry (ABMTRR), Royal Melbourne Hospital, Parkville, Australia
4Institute for Operations Research and Computational Finances, University of St Gallen, St Gallen, Switzerland
5The Eastern Mediterranean Blood and Marrow Transplant Group (EMBMT), King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
6Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan
7The Latin American Blood and Marrow Transplant Group (LABMT), Instituto Nacional de Cancer, Rio de Janeiro, Brazil
8National Marrow Donor Program, Minneapolis, USA
9Division of Hematology, Medical University of Graz, Graz, Austria
10The Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin, Milwaukee, USA
11The Asian Pacific Blood and Marrow Transplant Group (APBMT) Data Centre, Aichi Medical University, School of Medicine, Aichi, Japan
12The Canadian Blood and Marrow Transplant Group (CBMTG), Princess Margaret Hospital, Toronto, Canada
13The European Blood and Marrow Transplant Group (EBMT), Hôpital St Antoine, Paris
14The African Blood and Marrow Transplant Group (AFBMT), Johannesburg, South Africa
15The World Health Organization WHO, Geneva, Switzerland
16Aichi Medical University School of Medicine, Aichi, Japan
17Department of Hematology, Hammersmith Hospital, London, UK
18Department of Pediatric, Hospital Samaritano, Sao Paulo, Brazil

Tóm tắt

Từ khóa


Tài liệu tham khảo

World Health Organization. WHO guiding principles on human cell, tissue and organ transplantation. Transplantation 2010; 90: 229–233.

White SL, Hirth R, Mahíllo B, Domínguez-Gil B, Delmonico FL, Noel L et al. The global diffusion of organ transplantation: trends, drivers and policy implications. Bull World Health Organ 2014; 92: 826–835.

Gratwohl A, Baldomero H, Aljurf M, Pasquini MC, Bouzas LF, Yoshimi A et al. Worldwide Network of Blood and Marrow Transplantation. Hematopoietic stem cell transplantation: a global perspective. JAMA 2010; 303: 1617–1624.

Gratwohl A, Baldomero H, Gratwohl M, Aljurf M, Bouzas LF, Horowitz M et al. Worldwide Network of Blood and Marrow Transplantation (WBMT). Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study. Haematologica 2013; 98: 1282–1290.

Gratwohl A, Pasquini MC, Aljurf M, Yoshiko A, Helen B, Lydia F et al. For the Worldwide Network of Blood and Marrow Transplantation WBMT. One million haemopoietic stem- cell transplants: a retrospective observational study. Lancet Haematol 2015; 2: e91–100.

Copelan EA . Hematopoietic stem-cell transplantation. N Engl J Med 2006; 354: 1813–1826.

Sureda A, Bader P, Cesaro S, Dreger P, Duarte RF, Dufour C et al. Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015. Bone Marrow Transplant 2015; 50: 1037–1056.

Passweg JR, Baldomero H, Bader P, Bonini C, Cesaro S, Dreger P et al. European Society for Blood and Marrow Transplantation (EBMT). Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants. Bone Marrow Transplant 2015; 50: 476–482.

Hequet O . Hematopoietic stem and progenitor cell harvesting: technical advances and clinical utility. J Blood Med 2015; 6: 55–67.

Kurata M, Yanagisawa A, Atsuta Y, Sakamaki H, Kato K, Ichinohe T et al. Hematopoietic cell transplantation in Japan: nationwide survey 2013. Rinsho Ketsueki 2014; 55: 2381–2399.

Aljurf M, Rizzo JD, Mohty M, Hussain F, Madrigal A, Pasquini MC et al. Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries experts. Bone Marrow Transplant 2014; 49: 1016–1021.

Casebeer A . Application of SWOT analysis. Br J Hosp Med 1993; 49: 430–431.

Yamazaki H, Slingsby BT, Takahashi M, Hayashi Y, Sugimori H, Nakayama T . Characteristics of qualitative studies in influential journals of general medicine: a critical review. Biosci Trends 2009; 3: 202–209.

Reisner Y, Aversa F, Martelli MF . Haploidentical hematopoietic stem cell transplantation: state of art. Bone Marrow Transplant 2015; 50 (Suppl 2): S1–S5.

Ballen KK, Gluckman E, Broxmeyer HE . Umbilical cord blood transplantation: the first 25 years and beyond. Blood 2013; 122: 491–498.

Petrini C . Umbilical cord blood banking: from personal donation to international public registries to global bioeconomy. J Blood Med 2014; 5: 87–97.

Kekre N, Antin JH . Hematopoietic stem cell transplantation donor sources in the 21st century: choosing the ideal donor when a perfect match does not exist. Blood 2014; 124: 334–343; Erratum in: Blood 2015; 125: 1048.

Halter JP, van Walraven SM, Worel N, Bengtsson M, Hägglund H, Nicoloso de Faveri G et al. Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT). Bone Marrow Transplant 2013; 48: 220–225.

Kodera Y, Yamamoto K, Harada M, Morishima Y, Dohy H, Asano S et al. Japan Society for Hematopoietic Cell Transplantation. PBSC collection from family donors in Japan: a prospective survey. Bone Marrow Transplant 2014; 49: 195–200.

Vogl DT, Stadtmauer EA . High-dose chemotherapy and autologous hematopoietic stem cell transplantation for metastatic breast cancer: a therapy whose time has passed. Bone Marrow Transplant 2006; 37: 985–987.

Martin I, Ireland H, Baldomero H, Passweg J . The survey on cellular and engineered tissue therapies in Europe in 2012. Tissue Eng Part A 2015; 21: 1–13.